Induction of Metabolic Enzymes for Health Effects

  • Chang-Hwei Chen


Oxidative stress occurs when xenobiotic metabolic reactive intermediates such as reactive oxygen species or free radicals are neither readily detoxified by detoxification enzymes nor compensated for by the body’s antioxidant defense systems. Enzyme modulators are small molecules that exhibit induction or inhibition effects on activation or detoxification enzymes. The induction or inhibition of metabolic enzymes is an issue of complexity. Minimal xenobiotic toxicity is generally found in either a higher expression of detoxification enzyme activity or a fine balance rate between activation and detoxification expressions. Inducers of detoxification enzymes act as indirect antioxidants by boosting the body’s antioxidant systems, thus exerting antioxidant activities. Roles of Nrf2 and ARE on enzyme modulation and lifestyle modulation of metabolic enzymes are also discussed.


  1. Buetler TM, Gallagher EP, Wang C (1995) Induction of phase I and phase II drug metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol Appl Pharmacol 135:45–57CrossRefGoogle Scholar
  2. Chen CH (2012) Activation and detoxification enzymes: functions and implications. Springer Sciences, New YorkCrossRefGoogle Scholar
  3. Conney AH (2003) Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture. Cancer Res 63:7005–7031PubMedGoogle Scholar
  4. Cuendet M, Oteham CP, Moon RC et al (2006) Quinone reductase induction as a biomarker for cancer chemoprevention. J Nat Prod 69:460–463CrossRefGoogle Scholar
  5. Dinkova-Kostova AT, Talalay P (2008) Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 52(Suppl l):S128–S138PubMedGoogle Scholar
  6. Finley JW (2003) The antioxidant responsive element (ARE) may explain the protective effects of cruciferous vegetables on cancer. Nutr Rev 61:250–254CrossRefGoogle Scholar
  7. Hodges RE, Minich DM (2015) Modulation of metabolic detoxification pathways using foods and food-derived components: a scientific review with clinical application. J Nutr Metab 2015:760689CrossRefGoogle Scholar
  8. Jakel RJ, Townsend JA, Kraft AD, Johnson JA (2007) Nrf2-mediated protection against 6-hydroxydopamine. Brain Res 1144:192–201CrossRefGoogle Scholar
  9. Kensler TW, Curphey TJ, Maxiutenko Y et al (2000) Chemoprotection by organosulfur inducer of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabol Drug Interact 17(1–4):3–22PubMedGoogle Scholar
  10. Liu Y, Kern JT, Walker JR et al (2007) A genomic screen for activators of the antioxidant response element. Proc Natl Acad Sci 104:5205–5210CrossRefGoogle Scholar
  11. Manson MM, Ball HW, Barrett MC et al (1997) Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B I metabolism. Carcinogenesis 18:1729–1738CrossRefGoogle Scholar
  12. Murphy SE, Nunes MG, Hatala MA (1997) Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(metIlylnitrosamino)-I-(3pyridyl)-I-butanone, NNK. Chem Biol Interact 103:153–166CrossRefGoogle Scholar
  13. Murray M (2006) Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab 7:67–81CrossRefGoogle Scholar
  14. Nguyen T, Sherratt PJ, Pickett CB (2002) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43:233–260CrossRefGoogle Scholar
  15. Okey AB, Roberts EA, Harper PA et al (1986) Induction of drug-metabolizing enzymes: mechanisms and consequences. Clin Biochem 19:132–141CrossRefGoogle Scholar
  16. Prochaska HJ, TaJalay P (1998) Regulatory mechanisms ofmonofunctionaJ and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res 48:4776–4782Google Scholar
  17. Prochaska HJ, Santamaria AB, Talalay P (1992) Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci 89:2394–2398CrossRefGoogle Scholar
  18. Ramos-Gomez M, Kwak MK, Dolan PM et al (2001) Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci 98:3410–3415CrossRefGoogle Scholar
  19. Shen G, Kong AN (2009) Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm Drug Dispos 30:345–355CrossRefGoogle Scholar
  20. Talalay P (1989) Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Adv Enzyme Regul 28:237–250CrossRefGoogle Scholar
  21. Talalay P, Dinkova-Kostova AT, Holtzclaw WD (2003) Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul 43:121–134CrossRefGoogle Scholar
  22. Wu L, Noyan Ashraf MH, Facci M et al (2004) Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc Natl Acad Sci 101:7094–7099CrossRefGoogle Scholar
  23. Zevin S, Benowitz NL (1999) Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 36:425–438CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Chang-Hwei Chen
    • 1
  1. 1.Institute for Health and the Environment and Department of Biomedical SciencesUniversity at Albany, State University of New York, 5 University PlaceRensselaerUSA

Personalised recommendations